Weiner A, Erickson A L, Kansopon J, Crawford K, Muchmore E, Hughes A L, Houghton M, Walker C M
Chiron Corporation, Emeryville, CA 94608, USA.
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2755-9. doi: 10.1073/pnas.92.7.2755.
Hepatitis C virus (HCV) establishes a persistent infection in humans and chimpanzees despite the presence of virus-specific, class I major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes (CTLs) in the liver. The data presented here demonstrate that CTLs directed against a conserved epitope in the HCV nonstructural 3 protein persist in the liver of a chronically infected chimpanzee for at least 2 years after infection. However, these CTLs did not recognize the HCV quasi-species present in the plasma of this animal at week 16 postinfection or at later time points. Escape from the CTL response was facilitated by an aspartic acid to glutamic acid (D-->E) substitution at amino acid position 1449 in all HCV genomes that were sequenced. The results of this study strongly support the concept that CTL responses can select for variant viruses with an enhanced ability to persist in a host and have important implications for the design of vaccines against HCV.
尽管肝脏中存在病毒特异性、受I类主要组织相容性复合体限制的CD8 + 细胞毒性T淋巴细胞(CTL),丙型肝炎病毒(HCV)仍可在人类和黑猩猩中建立持续感染。本文提供的数据表明,针对HCV非结构3蛋白中保守表位的CTL在慢性感染的黑猩猩肝脏中在感染后至少持续2年。然而,这些CTL在感染后第16周或之后的时间点未能识别该动物血浆中存在的HCV准种。在所有测序的HCV基因组中,氨基酸位置1449处天冬氨酸到谷氨酸(D→E)的替换促进了对CTL反应的逃逸。本研究结果有力支持了CTL反应可选择具有在宿主中更强持续能力的变异病毒这一概念,并且对HCV疫苗设计具有重要意义。